SCHEMBL309287

SCHEMBL309287

OCc1ccc(N(c2ccc(CO)cc2)c2ccc(-c3ccc(N(c4ccc(CO)cc4)c4ccc(CO)cc4)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
TSHR P16473 1/20 0.42
KIF11 P52732 1/20 0.41
HDAC2 Q92769 1/20 0.40
HRH3 Q9Y5N1 4/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
VHL P40337 1/20 0.37
ELOC Q15369 1/20 0.37
ELOB Q15370 1/20 0.37
LTA4H P09960 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22941869 1.00 MKNK1 (0.45) MKNK1MKNK2TSHRKIF11HDAC2
SCHEMBL13599813 1.00 MKNK1 (0.45) MKNK1MKNK2TSHRKIF11HDAC2
SCHEMBL308282 0.92 TSHR (0.48) MKNK1MKNK2TSHRMEN1KMT2A
SCHEMBL14174075 0.91 TSHR (0.52) MKNK1MKNK2TSHRMEN1KMT2A
SCHEMBL22941864 0.91 TSHR (0.52) MKNK1MKNK2TSHRMEN1KMT2A
SCHEMBL10610530 0.91 TSHR (0.52) MKNK1MKNK2TSHRMEN1KMT2A
SCHEMBL13599818 0.91 LPL (0.43) MKNK1MKNK2TSHRKIF11HDAC2
SCHEMBL13599812 0.91 TSHR (0.52) MKNK1MKNK2TSHRMEN1KMT2A
SCHEMBL13818938 0.91 LPL (0.43) MKNK1MKNK2TSHRKIF11HDAC2
SCHEMBL14173670 0.91 TSHR (0.52) MKNK1MKNK2TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180004102-A1 METHOD FOR MANUFACTURING FLUORINATED STRUCUTURED ORGANIC PHOTORECEPTOR LAYERS XEROX CORPORATION 2018-01-04 US claimed
US-20180004103-A1 FLUORINATED STRUCUTURED ORGANIC FILM LAYERS XEROX CORPORATION 2018-01-04 US claimed
US-8591997-B2 Process for preparing structured organic films (SOFS) via a pre-SOF XEROX CORPORATION (US) 2013-11-26 US claimed
US-20240239967-A1 VISCOUS BIO-DERIVED SOLVENTS FOR STRUCTURED ORGANIC FILM (SOF) COMPOSITIONS XEROX CORPORATION (US) 2024-07-18 US disclosed
US-20240239967-A1 VISCOUS BIO-DERIVED SOLVENTS FOR STRUCTURED ORGANIC FILM (SOF) COMPOSITIONS XEROX CORPORATION (US) 2024-07-18 US disclosed
US-20240174808-A1 STRUCTURED ORGANIC FILMS CONTAINING N-CYCLIC QUATERNARY AMMONIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF XEROX CORPORATION (US) 2024-05-30 US disclosed
US-20240115975-A1 CATION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF XEROX CORPORATION (US) 2024-04-11 US disclosed
US-20240115974-A1 ANION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF XEROX CORPORATION (US) 2024-04-11 US disclosed
EP-4350821-A1 ANION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF Xerox Corporation (US) 2024-04-10 EP disclosed
US-20240110008-A1 STRUCTURED ORGANIC FILMS CONTAINING IMIDAZOLIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF XEROX CORPORATION (US) 2024-04-04 US disclosed
EP-4339231-A1 STRUCTURED ORGANIC FILMS CONTAINING IMIDAZOLIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF Xerox Corporation (US) 2024-03-20 EP disclosed
US-7560205-B2 Photoconductive imaging members XEROX CORPORATION (US) 2009-07-14 US disclosed
US-20090117476-A1 PROTECTIVE OVERCOAT LAYER AND PHOTORECEPTOR INCLUDING SAME XEROX CORPORATION (US) 2009-05-07 US disclosed
US-20090117476-A1 PROTECTIVE OVERCOAT LAYER AND PHOTORECEPTOR INCLUDING SAME XEROX CORPORATION (US) 2009-05-07 US disclosed
US-7229729-B2 Electrophotographic photoreceptor, process cartridge, image forming apparatus and image forming method KONICA MONOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-06-12 US disclosed
US-7229729-B2 Electrophotographic photoreceptor, process cartridge, image forming apparatus and image forming method KONICA MONOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2007-06-12 US disclosed
US-20070048636-A1 Photoconductive imaging members XEROX CORPORATION (US) 2007-03-01 US disclosed
US-20070048636-A1 Photoconductive imaging members XEROX CORPORATION (US) 2007-03-01 US disclosed
US-20070020540-A1 Silane-phenol compound, overcoat formulation, and electrophotographic imaging member XEROX CORPORATION 2007-01-25 US disclosed
US-20070020540-A1 Silane-phenol compound, overcoat formulation, and electrophotographic imaging member XEROX CORPORATION 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070020540-A1 Silane-phenol compound, overcoat formulation, and electrophotographic imaging member ARNT, STUB1, FLOT1 MKNK1 2291/4885MKNK2 2521/4885TSHR 3801/4885
US-20240174808-A1 STRUCTURED ORGANIC FILMS CONTAINING N-CYCLIC QUATERNARY AMMONIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF NONO, PAM, AQP4 MKNK1 4011/4885MKNK2 4030/4885TSHR 3228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.